Suppr超能文献

乳糜性腹水的一种罕见病因。

A rare cause of chylous ascites.

作者信息

Chen Yi-Ting, Chen Yung-Ming

机构信息

Renal Division, Department of Internal Medicine , E-DA Hospital , I-Shou University , Kaohsiung , Taiwan.

Renal Division, Department of Internal Medicine , National Taiwan University Hospital , Taipei , Taiwan ; Department of Internal Medicine , National Taiwan University Hospital, Yun-Lin Branch , Yun-Lin County , Taiwan.

出版信息

Clin Kidney J. 2014 Feb;7(1):71-2. doi: 10.1093/ckj/sft153. Epub 2013 Dec 29.

Abstract

We report a patient with end-stage renal disease status after two renal transplantations. Milky-like ascites was noted since the immunosuppressant agent was switched to sirolimus (1 mg/day). Chylous ascites was diagnosed owing to the triglyceride of dialysate to serum being 15.98:15.99. Series studies were all negative. It is highly suspected that the cause of chylous ascites is sirolimus related because surgically related lymph vessel injury happens most often 6 months after transplantation. Sirolimus-related chylous ascites is a rare cause of chylous ascites but the incidence rate increases after transplantation. Side effects of sirolimus include hyperlipidemia, anemia, thrombocytopenia, hepatotoxicity, delayed wound healing and a high rate of lymphoceles, lymph edema, and pulmonary alveolar proteinosis. Chylous ascitis has improved since the switch from sirolimus to other immunosuppressant agents.

摘要

我们报告了一位在两次肾移植术后处于终末期肾病状态的患者。自免疫抑制剂换用西罗莫司(1毫克/天)后,出现了乳糜样腹水。因透析液与血清甘油三酯比值为15.98:15.99,诊断为乳糜性腹水。系列检查均为阴性。高度怀疑乳糜性腹水的病因与西罗莫司有关,因为手术相关的淋巴管损伤最常发生在移植后6个月。西罗莫司相关的乳糜性腹水是乳糜性腹水的罕见病因,但移植后发病率增加。西罗莫司的副作用包括高脂血症、贫血、血小板减少、肝毒性、伤口愈合延迟以及淋巴囊肿、淋巴水肿和肺泡蛋白沉积症的高发生率。自将西罗莫司换为其他免疫抑制剂后,乳糜性腹水有所改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e655/4389166/9ecd93aeab60/sft15301.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验